Adjudication Machine learning DM Muscle Biomarkers Anti‐mitochondrial antibodies Gene therapy Polymyositis Immune checkpoint inhibitors Cardio-oncology Aldosterone Adult Biomarker Adeno-associated virus vector Myositis and muscle disease Antibodies Immunotherapy Anémie hémolytique Assisted communication devices IBM Outcome measures AAV humoral immunity Antiphospholipid syndrome Antisynthetase syndrome Antisynthétase Adolescence Cytokines Inclusion body myositis Anti-Mi2 Biomarqueurs Adeno-associated vector Active Idiopathic inflammatory myopathies Male COVID-19 Interferon Aldostérone Anti-MDA5 autoantibodies Bioelectrical impedance analysis Autoantibody Amyotrophic lateral sclerosis Middle Aged Abnormal movement Adverse drug reactions B-lymphocyte Interstitial lung disease Auto‐antibodies Acid-alpha-glucosidase Myocarditis Inflammation Skeletal muscle Lysosomal storage diseases Biopsy AAV vector Prognosis Analyses multidimensionnelles B cell homeostasis Systems biology Autoimmunity Antibody responses Multidisciplinarity Agalsidase Dependovirus/genetics/immunology Anti-drug antibodies Mass cytometry Auto-immunité Anti-synthetase syndrome Inflammatory myopathy Myopathy Arthritis IMNM Amyotrophy Dermatomyositis AAV antibody Adeno-associated virus Sphingosine-1-phosphate Humans AAV Auto-antibodies Anti-interleukin-6 Antisynthetase Fabry disease Anti-IgE IgG Inborn errors of metabolism Aged Autoimmune diseases Autoantibodies Data integration AAV vectors Cancer Myositis Deep immune profiling Anticorps anti-agalsidase Acute Kidney Injury/epidemiology/etiology Case reports Pharmacology Anti-agalsidase antibodies Anticorps spécifique des myosites Animals Female